Aspire Biopharma Holdings, Inc., an early-stage biopharmaceutical company, develops and markets disruptive technology for novel sublingual delivery mechanisms in the United States. It offers sublingual aspirin product that is a soluble, PH ...
Leadership
Kraig T. Higginson
Interim CEO, President & Executive Chairman of the Board
